Humanized Mouse Model Market Forecast (2021-2026)
Humanized Mouse Model Market size was valued at $83.29 million in 2020, and is anticipated to reach $86.98 million by the end of 2026 growing at a CAGR of 8.2% during the forecast period 2021-2026. The humanized mouse model industry growth rate is attributed to the growing incidences of chronic disorders and increasing demand for effective therapeutic drugs and is anticipated bringing new opportunities. Basic science, safety evaluation for large molecule therapeutics, simulation of some human-specific infectious diseases, and efficacy testing of immunotherapy approaches all use humanised mouse models. In both cells and tissues, the human protein is expressed, while the mouse protein is silenced. Humanized mouse models are used to study cancer genetics, Auto immune diseases, regenerative medicine, human hematopoiesis, infectious diseases, transplantation, and autoimmunity. They improve the translational value of preclinical research by allowing researchers to gain a better understanding of disease pathways. Apart from this, the model requires accurate risk assessment and thorough analysis to preserve the physiological expression and regulation of the human gene inserted into the mouse genome. The genes and proteins of both the mouse and the human are examined for accuracy and structure in order to determine the optimum expression and functionality of the human protein in a mouse environment. Nonetheless, speedy technological advancements have been seen in the area, leading to the development of transgenic mouse, knock-in mouse, and knock-out mouse.
Report Coverage
Inquiry Before Buying
Key Takeaways
- North America dominated the Humanized Mouse Model market with a share of 35.60% in the year 2020.
- The factors such as growing aging population and rising number of diagnostic imaging are amongst the major factor projected to impel growth of Humanized Mouse Model market.
- Additionally, factors such as development of automated diagnostic imaging systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnosis and increasing government investments are to create opportunities paving a way for the growth in the market during forecast period 2021-2026.
Humanized Mouse Model Market Segment Analysis - By Application
Humanized Mouse Model Market Segment Analysis - By End Users
On the basis of end users, contract research organizations (CROs) segment accounted for the largest segmental revenue of the humanized mouse model market in 2020. The largest share can be attributed to the rise in the number of pharmaceutical companies outsourcing their preclinical studies to CROs. In addition, contract research organisations (CROs) are focusing on using these models to produce new drugs in order to gain a profitable market share. They are also interested in drug toxicity assessment and preclinical analysis. Furthermore, biotechnology corporations fund basic and advanced medical and veterinary research programs.
On the other hand, academic & research institutes segment is projected to dominate over the forecast period 2021-2026 with a CAGR of 8.50%. Owing to the rising demand for mice models in academic institutions, academic and research institutes are expected to expand at a healthy rate. For pharmacology education, academic institutions use preserved mice models to understand drug toxicity behavior. In addition, these models are being used in academia to educate and prepare a new generation of scientists and facility managers. Yale University, for example, created a novel HIV drug that suppressed the HIV virus in humanised mice and was found to be less toxic. The University of Pittsburgh and Temple University conducted a related study to exclude HIV DNA from the genomes of humanised mice. Both of these factors would contribute to the growth of the segmental market.
Humanized Mouse Model Market Segment Analysis - By Geography
North America is the major region dominating the Humanized Mouse Model market with a market share of 35.60% in the year 2020. This can be attributed to the growth in this regional segment and can primarily be attributed to growing biomedical research, preclinical activities by CROs and pharmaceutical R&D, continued and responsible use of animals ensured by animal care organizations, increasing monoclonal antibody production in the US along with growing stem cell research, and government support for the development of protein drugs in Canada have fueled the regional market. Moreover, increasing number of research and development activities with increasing need for early-stage diagnose of various types of cancer & cardiovascular diseases are also driving regional market growth.
However, Asia-Pacific is projected to be the significant-growing market growth CAGR during the forecast period 2021-2026. This is owing to foreign R&D partnerships in China, which include measures to shorten drug approval times and mandate animal testing for both prescription drugs and cosmetics, resulting in increased government and private sector investment in China's life sciences sector. Apart from these, the creation of bio-clusters to boost India's biotechnology, growth in translational and biomedical research in Singapore, increase in animal research in Malaysia, and ongoing biomedical research activities in Australia are all expected to drive the market in the area.
Humanized Mouse Model Market Drivers
Rising Demand For Personalized Medicine
Humanized Mouse Model Market Challenges
High Cost Of Humanized Models
Humanized Mouse Model Market Landscape
Acquisitions/Product Launches
- In April 2019, Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOME®, a first of its kind solution enabling the generation and maintenance of mice with custom microbiome profiles.
Comments
Post a Comment